pharmaceutical investing Cellular Biomedicine Group Reports First Quarter 2018 Financial Results and Highlights Operational Progress
medical device investing Advanced Biomedical Technologies Inc. Announces Chinese CFDA Approval of Polymer Fixation Screws
pharmaceutical investing BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China
QIMC Extends DDH-26-05 Drilling to Beyond 1,000 Metres and Launches In-Situ Hydrogen Characterization and Extraction Program at Bennett Hill as Seismic Further Corroborates Two Distinct Hydrogen Systems in Nova Scotia